tickrz reports
Amgen Inc (AMGN)
Healthcare | Drugs
185.70  0.27%
AMGN vs DRUGS SECTOR & S&P 500
VALUATION
AMGNSECTORS&P 500
P/E RATIO16.5940.521.12
EV/EBITDA RATIO9.98133.412.66
P/S RATIO5.896.52.25
P/B RATIO4.217.73.45
QUALITY
RETURN ON EQUITY25.96%15.79%13.64%
RETURN ON CAPITAL31.55%19.38%10.09%
NET MARGIN34.04%14.46%9.73%
DIVIDEND ANALYSIS
DIVIDEND YIELD
2.49%
PAYOUT RATIO40.08%
3 YR DIVIDEND GROWTH28.62%
FINANCIAL STRENGTH
PIOTROSKI F SCORE
8 OUT OF 9
DEBT-TO-EQUITY111%
INTEREST COVERAGE7.8x
CURRENT RATIO6.07
GROWTH
5 YR EPS GROWTH20.44%
5 YR SPS GROWTH7.65%
5 YR BPS GROWTH11.09%
Amgen Inc Filings

Annual & Quarterly Reports

Events or Changes Between Quarters (8-K)


Changes in Ownership